A Research and Clinical Advisory Panel [RCAP] met in 2010 (Bone Summit) to review medical and research data of long-duration astronauts in order to make recommendations for the risk management for early onset osteoporosis in long duration astronauts. In its assessment, the RCAP stated that the guidelines using bone mineral density [BMD] T-scores as diagnostic criteria for osteoporosis have minimal clinical utility for the younger aged (< 50 years), predominantly male, astronaut cohort following exposure to prolonged spaceflight. In addition, NASA’s research data have revealed that DXA measurement of hip BMD does not capture all of the effects of spaceflight that influence bone strength (Keyak et al., Bone 2009; 44(3):449-53). The Bone Summit RCAP recommended that NASA explore emerging population studies that use hip bone strength, as estimated from Finite Element [FE] models of QCT [quantitative computed tomography] scans, to supplement DXA bone mineral density [BMD] as a combined standard for bone health (Orwoll et al., J Bone Miner Res 2013; 28(6):1243-1255). To this aim, the Bone Discipline Lead (named as Principal Investigator), convened a Task Group of US principal investigators and FE modelers of those QCT population studies, along with one non-advocate FE modeler, to propose a FEM-based method by which bone medical standards could be modified. The FE strength cutoffs that are generated by this proposed method will be reviewed, modified if required, and accepted for recommendation by the FE Task Group as a bone health medical standard specific for astronauts exposed to the spaceflight environment.
Specific Aims
NASA’s Bone medical standards establish the “operating bands for bone health” that: a) qualify an astronaut for long duration spaceflights, b) establish the non-permissible outcome for a spaceflight mission, c) provide a level of efficacy for countermeasures as well as d) screen for optimal bone health in an applicant for the astronaut corps. The current Bone medical standards are based upon the diagnostic criteria for a terrestrial population known to be at risk for osteoporosis, i.e., perimenopausal and postmenopausal women and men over the age of 50.
As a follow-up to the Bone Summit RCAP recommendation, the FE Task Group proposes the following Specific Aims to accomplish the task of generating of FE-based medical standards to supplement the existing BMD T-score-based standards:
1) Develop a dataset of FE hip strengths from human subjects, with ages covering the age range of the astronauts and for which fracture outcome data have been collected.
a. The Rochester Bone Health Study (as authorized by Drs. Sundeep Khosla and Shreyasee Amin) will provide QCT scans from ~408 persons to Dr. Joyce Keyak who will develop FE models and estimate hip bone strength using the FE modeling developed at University of Califormia Irvine (Keyak JH, et al. Clin Orthop Relat Res. 2005 Aug;(437):219-28).
b. FE data from 1a (above) will be combined with FE data generated from other applications of Keyak FEM to QCT scans from additional study cohorts, which include International Space Station (ISS) astronauts.
2) Determine FE strength cutoffs, from Specific Aim 1b, to be used as a decision-tool by Space & Clinical Operations Division for the following scheduled decision points (a-d):
a. to qualify a sub-set of applicants for astronaut candidacy (those who currently are not qualified due to hip T-score between -1 and -1.5) for further medical testing
b. to qualify an astronaut for a long-duration (LD) mission
c. to qualify a veteran LD astronaut for a second LD mission
d. to establish responsibility by occupational space medicine for a post-mission fracture or osteoporosis diagnosis.
3) Present, review, and finalize the generated FE strength cutoffs with FE Task Group (along with the inclusion of cohort biostatisticians) to recommend to Human Health Countermeasures as a deliverable to the Space Medicine Space & Clinical Operations Division and Office of Chief Health and Medical Officer.
(Ed. note: revised version, per PI. 8/27/2013) |